Company Regen BioPharma, Inc. OTC Markets
Equities
RGBPP
US75886M4096
Biotechnology & Medical Research
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.5 USD | +48.51% | 0.00% | -36.40% |
Business Summary
Number of employees: 1
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Regenerative Medical Applications
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +0.44% |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | 100.0 % | 0 | 100.0 % | +0.44% |
Managers
Managers | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
David Koos
CEO | Chief Executive Officer | 64 | 12-04-23 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 0 | 29,338 | 0 | 0 | 99.99 % |
Stock B | 0 | 34 | 0 | 0 | |
Stock C | 1 | 4,114,622 | 4,114,118 ( 99.99 %) | 0 | |
Stock D | 0 | 409,551 | 0 | 0 |
Company contact information
Regen Biopharma, Inc.
4700 Spring Street Suite 304
91942, La Mesa
+619 722 5505
http://www.regenbiopharmainc.comSector
1st Jan change | Capi. | |
---|---|---|
+16.49% | 122B | |
+21.73% | 116B | |
+22.18% | 27.03B | |
-21.81% | 20.36B | |
-16.89% | 16.43B | |
-18.81% | 15.91B | |
-44.74% | 15.6B | |
+62.72% | 14.94B | |
+3.09% | 13.59B |
- Stock Market
- Equities
- RGBP Stock
- RGBPP Stock
- Company Regen BioPharma, Inc.